<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Between 1986 and 1989 (4 years), 11 epithelial <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">malignant tumours of the ovary</z:e> were treated in the department of gynecology and obstetrics of the Libreville teaching hospital group </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">Epithelial tumours</z:e> accounted for 78 per cent of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignant tumours</z:e> in the adult </plain></SENT>
<SENT sid="2" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> predominated in young girls </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1140680,C0029925" disease_type="Neoplastic Process" abbrv="">Cancer of the ovary</z:e> takes sixth place among female <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in Gabon, with an incidence identical to that of <z:e sem="disease" ids="C0279000,C0345904" disease_type="Neoplastic Process" abbrv="">cancer of the liver</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Cases involved stage III and IV <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Four patients died (36 per cent) and seven are still alive (63.6 per cent) with a mean survival of 25 months at the time of the study (the longest living patient having a survival of 5 years) </plain></SENT>
<SENT sid="6" pm="."><plain>The fullest possible initial surgical excision is essential in ensuring the greater efficacy of polychemotherapy (including <z:chebi fb="2" ids="27899">Cisplatin</z:chebi>), the only guarantee of total second look surgery </plain></SENT>
<SENT sid="7" pm="."><plain>Monitoring of <z:e sem="disease" ids="C0543478" disease_type="Neoplastic Process" abbrv="">residual disease</z:e> was based upon ultrasonography </plain></SENT>
<SENT sid="8" pm="."><plain>Pelvic radiotherapy was used in the presence of a residual pelvic mass measuring less than 3 cm </plain></SENT>
<SENT sid="9" pm="."><plain>Future efforts must be direct towards early detection, in particular since more than 45 per cent of our patients were aged under 30 </plain></SENT>
</text></document>